Roger G. Harrison

2.8k total citations
47 papers, 1.7k citations indexed

About

Roger G. Harrison is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, Roger G. Harrison has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Genetics. Recurrent topics in Roger G. Harrison's work include Cancer Research and Treatments (8 papers), Virus-based gene therapy research (7 papers) and Protein purification and stability (7 papers). Roger G. Harrison is often cited by papers focused on Cancer Research and Treatments (8 papers), Virus-based gene therapy research (7 papers) and Protein purification and stability (7 papers). Roger G. Harrison collaborates with scholars based in United States, France and Venezuela. Roger G. Harrison's co-authors include Gregory D. Davis, Daniel E. Resasco, Miguel J. Bagajewicz, Paul Todd, Demetri P. Petrides, Scott R. Rudge, Yongqiang Tan, John J. Krais, David W. Schmidtke and B. Lythgoe and has published in prestigious journals such as Nano Letters, Blood and Nature Biotechnology.

In The Last Decade

Roger G. Harrison

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger G. Harrison United States	21	1.1k	302	239	189	186	47	1.7k
Alethea B. Tabor United Kingdom	27	1.3k 1.2×	258 0.9×	161 0.7×	129 0.7×	223 1.2×	88	2.0k
Tae Hyeon Yoo South Korea	24	1.2k 1.1×	304 1.0×	133 0.6×	235 1.2×	133 0.7×	65	1.8k
Nick Geukens Belgium	24	903 0.8×	387 1.3×	127 0.5×	176 0.9×	473 2.5×	86	1.9k
Paul Bessette United States	14	959 0.9×	448 1.5×	129 0.5×	287 1.5×	282 1.5×	17	1.8k
Seok‐Joon Kwon United States	27	1.3k 1.2×	627 2.1×	203 0.8×	90 0.5×	109 0.6×	70	2.2k
Wim Noppe Belgium	22	908 0.8×	202 0.7×	202 0.8×	102 0.5×	184 1.0×	31	1.5k
Takeshi Yagami Japan	21	1.7k 1.6×	170 0.6×	347 1.5×	70 0.4×	312 1.7×	52	2.7k
Alain J. P. Alix France	25	930 0.9×	245 0.8×	178 0.7×	113 0.6×	520 2.8×	88	2.3k
Luca Domenico D’Andrea Italy	26	2.1k 1.9×	219 0.7×	236 1.0×	194 1.0×	215 1.2×	90	3.0k
Viktor Menart Slovenia	15	996 0.9×	202 0.7×	98 0.4×	340 1.8×	180 1.0×	28	1.4k

Countries citing papers authored by Roger G. Harrison

Since Specialization

Citations

This map shows the geographic impact of Roger G. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger G. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger G. Harrison more than expected).

Fields of papers citing papers by Roger G. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger G. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger G. Harrison. The network helps show where Roger G. Harrison may publish in the future.

Co-authorship network of co-authors of Roger G. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Roger G. Harrison. A scholar is included among the top collaborators of Roger G. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger G. Harrison. Roger G. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silvy, Ricardo Prada, et al.. (2024). Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1. Journal of Pharmacology and Experimental Therapeutics. 390(1). 65–77. 3 indexed citations

Harrison, Roger G., et al.. (2022). Annexin A5 as a targeting agent for cancer treatment. Cancer Letters. 547. 215857–215857. 23 indexed citations

Yang, Wen, Lin Wang, Nathan D. Donahue, et al.. (2022). Controlling Nanoparticle Uptake in Innate Immune Cells with Heparosan Polysaccharides. Nano Letters. 22(17). 7119–7128. 24 indexed citations

Silvy, Ricardo Prada, et al.. (2021). Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer. Nanoscale Research Letters. 16(1). 9–9. 50 indexed citations

Battiste, James, et al.. (2020). Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli. International Journal of Antimicrobial Agents. 56(6). 106183–106183. 1 indexed citations

Liu, Hong, et al.. (2019). Enhanced computed tomography imaging of breast cancer via phosphatidylserine targeted gold nanoparticles. Biomedical Physics & Engineering Express. 5(6). 65019–65019. 4 indexed citations

Thavathiru, Elangovan, et al.. (2018). Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer. Cancer Letters. 425. 174–182. 23 indexed citations

Krais, John J., et al.. (2017). Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Molecular Cancer Therapeutics. 16(9). 1855–1865. 10 indexed citations

Davis, Carole, Paul Hauser, Robert E. Hurst, et al.. (2017). Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer. Nanotechnology. 29(3). 35101–35101. 43 indexed citations

10.

Guillen, Katrin P., et al.. (2016). Annexin-directed β-glucuronidase for the targeted treatment of solid tumors. Protein Engineering Design and Selection. 30(2). 85–94. 8 indexed citations

11.

Guillen, Katrin P., et al.. (2015). Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer. Pancreas. 44(6). 945–952. 4 indexed citations

12.

Krais, John J., et al.. (2013). Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology. 24(37). 375104–375104. 54 indexed citations

13.

Harrison, Roger G., et al.. (2011). Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Letters. 307(1). 53–61. 19 indexed citations

14.

Resasco, Daniel E., et al.. (2011). Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 22(45). 455101–455101. 20 indexed citations

15.

Tomba, Emanuele, et al.. (2009). Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnology and Bioengineering. 105(2). 374–383. 68 indexed citations

16.

Huang, Xin, Wei-Qun Ding, Roman F. Wolf, et al.. (2005). A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 107(3). 980–986. 22 indexed citations

17.

Davis, Gregory D., et al.. (1998). Recombinant production and purification of novel antisense antimicrobial peptide inEscherichia coli. Biotechnology and Bioengineering. 57(1). 55–61. 45 indexed citations

18.

Harrison, Roger G., et al.. (1991). Predicting the Solubility of Recombinant Proteins in Escherichia coli. Nature Biotechnology. 9(5). 443–448. 176 indexed citations

19.

Harrison, Roger G., et al.. (1991). Purification of Prephenate Dehydratase fromCorynebacterium Glutamicumby Affinity Chromatography. Preparative Biochemistry. 21(4). 269–275. 2 indexed citations

20.

Sreekrishna, Koti, W. Richard McCombie, Lynn P. Nelles, et al.. (1988). High level expression of heterologous proteins in methylotrophic yeast Pichia pastoris. Journal of Basic Microbiology. 28(4). 265–278. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact